Aurora Cannabis Announces $6 Million Private Placement

Aurora Cannabis Inc. has agreed to a one-time special accommodation for the benefit of its underwriters due to very significant demand for the Bought Deal, to proceed with a concurrent, non-commissioned, non-brokered private placement of up to 2,000,000 units of the Company (the "Units") at a price of $3.00 per Unit (the "Offering").

Emblem Announces $25 Million Bought Deal

Emblem Corp. (TSX VENTURE:EMC)(TSX VENTURE:EMC.WT) announces that it has entered into a letter of engagement with Eight Capital under which Eight Capital has agreed to purchase 5,714,300 units (the "Units") and 15,000 convertible unsecured debentures of the Company

Plus Receives $2M Series A for Cannabis-Infused Products

Plus, the cannabis infused products manufacturer, is pleased to announce the closing of its Series A financing. The Financing was comprised of $2 Million USD of Series A Preferred Stock (the “Shares”), and was led by The Green Opportunity Funds.

ABcann Global Puts The 'Green' In Green Rush

Seekingalpha.com recently posted an in-depth article looking at ABcann Global (TSX.V: ABCN OTCQB: ABCCF) and how well positioned it is in this emerging market. It's a great read for those interested in this company that we've identified as one of Canada's Strongest Growers.

5 CANNABIS BIOTECH STOCKS TO WATCH

These 5 Biotechs including InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) have a combined market cap of over $4 Billion. What should investors know about future growth for these companies?